IDS provides laboratories worldwide with clinical and research solutions in the field of specialty endocrinology. We aim to enhance laboratory efficiency, improve diagnostic accuracy and enrich diagnostic outcomes for patients.
WHO WE ARE
Immunodiagnostic Systems (IDS) is a leading in-vitro diagnostic solution provider to the clinical laboratory market. IDS was founded in 1977 and trades on the Alternative Investment Market (AIM; trading symbol IDH) of the London Stock Exchange. We are a global company headquartered in the UK with around 275 employees worldwide. Our products are developed and manufactured at our facilities in Europe. We serve our customers through regional offices in Europe, the USA and we have sales offices in Brazil. Our network of distributors work on our behalf to serve our customers throughout the rest of the world.
We develop, manufacture, and market innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients. Our immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels from complementary fields.